MedPath

Precision Dose, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

FDA:41

Drug Approvals

Famotidine

Approval Date
May 27, 2025
FDA

Guaifenesin Extended-Release

Approval Date
May 27, 2025
FDA

Diazepam

Approval Date
Apr 2, 2024
FDA

Megestrol Acetate

Approval Date
Mar 28, 2024
FDA

Megestrol Acetate

Approval Date
Mar 28, 2024
FDA

Ondansetron Hydrochloride

Approval Date
Mar 12, 2024
FDA

PHENTOLAMINE MESYLATE

Approval Date
Jan 23, 2024
FDA

Sucralfate

Approval Date
Jan 16, 2024
FDA

Levetiracetam

Approval Date
Jan 15, 2024
FDA

Midazolam Hydrochloride

Approval Date
Dec 22, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.